Advanced search
Publication Cover
International Journal of General Medicine Volume 14, 2021 - Issue
Submit an article Journal homepage
105
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Five-Year Outcomes of Post-Drug-Coated Balloon Angioplasty Dissection in Complex Femoropopliteal Artery Disease

Hao Ren1 Medical School of Chinese PLA, Beijing, 100853, People’s Republic of China;2 Department of Vascular Surgery, Dalian Municipal Central Hospital, Dalian, 116033, People’s Republic of China
,
Jie Liu1 Medical School of Chinese PLA, Beijing, 100853, People’s Republic of China;3 Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China
,
Jiwei Zhang4 Department of Vascular Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200120, People’s Republic of China
,
Baixi Zhuang5 Department of Vascular Surgery, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100080, People’s Republic of China
,
Weiguo Fu6 Department of Vascular Surgery, Zhongshan Hospital Fudan University, Shanghai, 200032, People’s Republic of China
,
Danming Wu7 Department of Vascular Surgery, The People’s Hospital of Liaoning Province, Shenyang, 110016, People’s Republic of China
,
Feng Wang8 Department of Interventional Therapy, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People’s Republic of China
,
Yu Zhao9 Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400042, People’s Republic of China
,
Pingfan Guo10 Department of Vascular Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, People’s Republic of China
,
Wei Bi11 Department of Vascular Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, 050073, People’s Republic of China
,
Shenming Wang12 Department of Vascular Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510055, People’s Republic of China
&
Wei Guo1 Medical School of Chinese PLA, Beijing, 100853, People’s Republic of China;3 Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 4197-4207 | Published online: 05 Aug 2021

References

  • Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358(7):689–699. doi:10.1056/NEJMoa0706356
  • Laird JR, Schneider PA, Tepe G, et al. Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol. 2015;66(21):2329–2338. doi:10.1016/j.jacc.2015.09.063
  • Thieme M, Bilderling PV, Paetzel C, et al. The 24-month results of the Lutonix Global SFA registry: worldwide Experience with lutonix drug-coated balloon. JACC Cardiovasc Interv. 2017;10(16):1682–1690. doi:10.1016/j.jcin.2017.04.041
  • Brodmann M, Werner M, Meyer DR, et al. Sustainable antirestenosis effect with a low-dose drug-coated balloon: the ILLUMENATE European Randomized Clinical Trial 2-year results. JACC Cardiovasc Interv. 2018;11(23):2357–2364. doi:10.1016/j.jcin.2018.08.034
  • Tepe G, Zeller T, Schnorr B, et al. High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther. 2013;20(6):792–800. doi:10.1583/13-4392R.1
  • Tepe G, Schnorr B, Albrecht T, et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv. 2015;8(1 Pt A):102–108. doi:10.1016/j.jcin.2014.07.023
  • Laird JA, Schneider PA, Jaff MR, et al. Long-term clinical effectiveness of a drug-coated balloon for the treatment of femoropopliteal lesions. Circ Cardiovasc Interv. 2019;12(6):e007702. doi:10.1161/CIRCINTERVENTIONS.118.007702
  • Ren H, Liu J, Zhang J, et al. Association between post-balloon angioplasty dissection and primary patency in complex femoropopliteal artery disease: 2-year clinical outcomes of the AcoArt I trial. J Int Med Res. 2021;49(4):3000605211006546. doi:10.1177/03000605211006546
  • Jia X, Zhang J, Zhuang B, et al. Acotec drugcoated balloon catheter randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial. JACC Cardiovasc Interv. 2016;9(18):1941–1949. doi:10.1016/j.jcin.2016.06.055
  • Xu Y, Jia X, Zhang J, et al. Drug-coated balloon angioplasty compared with uncoated balloons in the treatment of 200 Chinese patients with severe femoropopliteal lesions: 24-month results of AcoArt I. JACC Cardiovasc Interv. 2018;11(23):2347–2353. doi:10.1016/j.jcin.2018.07.041
  • Xu Y, Liu J, Zhang J, et al. Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial. J Vasc Surg. 2021: S0741–5214(21)00184–1.
  • Katsanos K, Spiliopoulos S, Kitrou P, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(24):e011245. doi:10.1161/JAHA.118.011245
  • UPDATE: treatment of peripheral arterial disease with paclitaxel-coated balloons and paclitaxel-eluting stents potentially associated with increased mortality - letter to health care providers. FDA. March 15, 2019 [updated April 23, 2019]. Available from: https://www.fda.gov/medical-devices/letters-health-care-providers/update-treatment-peripheral-arterial-disease-paclitaxel-coated-balloons-and-paclitaxel-eluting. Accessed May 23, 2019.
  • Bonassi S. Letter by Bonassi regarding article, “Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a Systematic Review and Meta-Analysis of Randomized Controlled Trials”. J Am Heart Assoc. 2019;8(10):e012315. doi:10.1161/JAHA.119.012315
  • Ouriel K, Adelman MA, Rosenfield K, et al. Safety of paclitaxel-coated balloon angioplasty for femoropopliteal peripheral artery disease. JACC Cardiovasc Interv. 2019;12(24):2515–2524. doi:10.1016/j.jcin.2019.08.025
  • Schneider PA, Laird JR, Doros G, et al. Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon. J Am Coll Cardiol. 2019;73(20):2550–2563. doi:10.1016/j.jacc.2019.01.013
  • Secemsky EA, Kundi H, Weinberg I, et al. Association of survival with femoropopliteal artery revascularization with drug-coated devices. JAMA Cardiol. 2019;4(4):332–340. doi:10.1001/jamacardio.2019.0325

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.